NovoCure Ltd (NVCR) Financial Statements (2026 and earlier)

Company Profile

Business Address NO. 4 THE FORUM
ST. HELIER,
State of Incorp.
Fiscal Year End December 31
Industry (SIC) 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments959,873910,616969,425937,700842,576326,090
Cash and cash equivalent163,767240,821115,326208,802234,674177,321
Short-term investments796,106669,795854,099728,898607,902148,769
Restricted cash and investments2,3271,74350880711,4992,095
Receivables74,22661,22186,26193,56796,69958,859
Inventory, net of allowances, customer advances and progress billings35,08638,15229,37624,42727,42223,701
Inventory35,08638,15229,37624,42727,42223,701
Prepaid expense7,2176,7846,1954,7113,9632,251
Other undisclosed current assets27,84615,89319,76412,31417,28226,951
Total current assets:1,106,5751,034,4091,111,5291,073,526999,441439,947
Noncurrent Assets
Operating lease, right-of-use asset27,12034,83523,59618,26719,009 
Property, plant, and equipment, after accumulated depreciation, depletion, and amortization77,66051,47932,67822,69311,3959,342
Other noncurrent assets14,61814,02211,16112,08610,9084,904
Other undisclosed noncurrent assets14,81111,38412,68412,92311,23025,255
Total noncurrent assets:134,209111,72080,11965,96952,54239,501
TOTAL ASSETS:1,240,7841,146,1291,191,6481,139,4951,051,983479,448
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities153,257153,757132,089119,04390,50762,528
Employee-related liabilities39,59030,31620,904
Accounts payable105,08694,39185,19772,60053,64736,925
Accrued liabilities48,17159,36646,8926,8536,5444,699
Deferred revenue14,22516,224    
Debt 558,160     
Other undisclosed current liabilities30,7349,13426,68823,55923,10523,783
Total current liabilities:756,376179,115158,777142,602113,61286,311
Noncurrent Liabilities
Long-term debt and lease obligation  568,822565,509575,213444,198149,424
Long-term debt, excluding current maturities  568,822565,509562,216429,905149,424
Liabilities, other than long-term debt19,98927,43821,7886,64312,47623,715
Deferred revenue   2,8786,47712,139 
Contract with customer, liability7,807
Liability, pension and other postretirement and postemployment benefits      15,686
Other liabilities 1818148166337222
Operating lease, liability19,97127,42018,76212,99714,293 
Other undisclosed noncurrent liabilities104,2408,2584,4044,5435,1712,208
Total noncurrent liabilities:124,229604,518591,701586,399461,845175,347
Total liabilities:880,605783,633750,478729,001575,457261,658
Equity
Equity, attributable to parent360,179362,496441,170410,494476,526217,790
Additional paid in capital1,519,8091,353,4681,222,0631,099,5891,111,435871,442
Accumulated other comprehensive loss(5,500)(5,469)(2,433)(3,169)(3,832)(2,767)
Accumulated deficit(1,154,130)(985,503)(778,460)(685,926)(631,077)(650,885)
Total equity:360,179362,496441,170410,494476,526217,790
TOTAL LIABILITIES AND EQUITY:1,240,7841,146,1291,191,6481,139,4951,051,983479,448

Income Statement (P&L) ($ in thousands)

12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Revenues605,220509,338537,840535,031494,366351,318
Cost of revenue(137,181)(128,280)(114,867)(114,877)(106,501)(88,606)
Gross profit:468,039381,058422,973420,154387,865262,712
Operating expenses(638,535)(613,928)(512,496)(464,487)(357,464)(263,626)
Operating income (loss):(170,496)(232,870)(89,523)(44,333)30,401(914)
Nonoperating income
(Investment Income, Nonoperating)
50,99746,03615,790   
Interest and debt expense  (4,906)(8,113)(7,742)(12,299)(7,910)
Income (loss) from continuing operations before equity method investments, income taxes:(119,499)(191,740)(81,846)(52,075)18,102(8,824)
Other undisclosed loss from continuing operations before income taxes(11,663)     
Income (loss) from continuing operations before income taxes:(131,162)(191,740)(81,846)(52,075)18,102(8,824)
Income tax expense (benefit)(37,465)(15,303)(10,688)(6,276)1,7061,594
Income (loss) from continuing operations:(168,627)(207,043)(92,534)(58,351)19,808(7,230)
Income (loss) before gain (loss) on sale of properties:(58,351)19,808(7,230)
Net income (loss) available to common stockholders, diluted:(168,627)(207,043)(92,534)(58,351)19,808(7,230)

Comprehensive Income ($ in thousands)

12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Net income (loss):(168,627)(207,043)(92,534)(58,351)19,808(7,230)
Other comprehensive income (loss)(31)(3,036)736663(1,065)(1,367)
Comprehensive income (loss), net of tax, attributable to parent:(168,658)(210,079)(91,798)(57,688)18,743(8,597)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: